Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Taiwania Capital

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 61
Average round size
The average size of a deal this fund participated in
Portfolio companies 44
Rounds per year 12.20
Lead investments 9
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 4
Key employees 7

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Manufacturing

The leading representative office of defined VC is situated in the Taipei. The fund was located in Asia if to be more exact in Taiwan.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Taiwania Capital, startups are often financed by Tyche Partners, R7 Partners, Latterell Venture Partners. The meaningful sponsors for the fund in investment in the same round are Tyche Partners, Korea Investment Partners, Kleiner Perkins. In the next rounds fund is usually obtained by RTW Investments LLC, Polaris Founders Capital, Perceptive Advisors.

We also calculated 7 valuable employees in our database.

The top activity for fund was in 2019. Opposing the other organizations, this Taiwania Capital works on 12 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 63 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019.

Among the most popular portfolio startups of the fund, we may highlight AEye, Pavilion Data Systems, Viracta Therapeutics. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Taiwania Capital:
Typical Co-investors
Taiwania Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Taiwania Capital:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angel Hub -
Angel Round Capital Las Vegas, Nevada, United States
Beijing Financial Street Capital Operation Center Beijing, Beijing, China
Convivialite Ventures California, San Francisco, United States
CXO Fund California, San Jose, United States
DBS - NUS Social Venture Challenge Asia Central, Central Region, Singapore
Denham Capital Boston, Massachusetts, United States
EnergyFunders Houston, Texas, United States
FSP Ventures Austria, Vienna
Insight China, Shanghai
IPI Technolab -
Kuramo Capital New York, New York, United States
LeBox Capital Beijing, Beijing, China
Longxi Real Estate -
Nextpoint Chicago, Illinois, United States
Signature Bank New York, New York, United States
Two Point O Fund -
Varma Mutual Pension Insurance Company Finland, Helsinki, Southern Finland
VStone China, Huangpu, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


16 Aug 2022 Taipei, Taiwan

Fractyl Laboratories

Health Care
Medical Device
15 Aug 2022 Massachusetts, United States

Aesop Technology

Artificial Intelligence
Digital Media
Health Care
$3M01 Jul 2022 Cambridge, Massachusetts, United States

Verana Networks

$28M06 Apr 2022 Massachusetts, United States


3D Technology
$20M04 Apr 2022 Vaud, Switzerland


Big Data
Business Intelligence
Data Mining
Data Visualization
$3M08 Mar 2022 New Taipei, Taiwan

Pavilion Data Systems, Inc.

Data Center
Data Storage
Data Visualization
Information Technology
$45M20 Jan 2022 San Jose, California, United States


Information Technology
Network Security
$7M16 Dec 2021 Palo Alto, California, United States


Industrial Engineering
Mechanical Engineering
$88M09 Nov 2021 Berkeley, California, United States
Elixiron Immunotherapeutics Closes $27M Series A-1 Financing Round

– Elixiron Immunotherapeutics from San Francisco develops therapeutics for cancer, neurological diseases and inflammatory disorders.
– The company closed a $27m Series A-1 extension financing round.
– The round was jointly led by Pangu Capital (a new investor) and Taiwania Capital (an existing investor) and was joined by further new investors, including DCI Partners of Daiwa Securities Group, Mega International Commercial Bank, Fubon Financial Holdings and Hong Tai Electric Industrial, as well as other existing investors such as China Development Capital Industrial Bank (CDIB) Capital Group.
– The company intends to use the funds to advance phase 1 trials of two pipeline candidates and take three immuno-oncology assets towards IND applications.

SaaS Solutions Provider Kdan Mobile Software Raises $16M in Series B Funding From Group of Tier-One Global Investors

– Kdan Mobile Software Ltd. announced $16M Series B funding.
– The round was led by Dattoz Partners, WI Harper Group, Taiwania Capital and Golden Asia Fund Mitsubishi UFJ Capital.
– Kdan is a SaaS company that designs and provides cloud-based productivity and content creation solutions for desktop, web and mobile environments.
– The round will be used to accelerate its global expansion.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Taiwania Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: